FDA Adds Boxed Warning to Iron Replacement Injection
(MedPage Today) -- The FDA approved a label change for ferric carboxymaltose injection (Injectafer) that adds a boxed warning for the risk of symptomatic hypophosphatemia. The agency recommends monitoring of phosphate levels in patients at risk...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.